Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2002
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report
M Marchand, C J A Punt, S Aamdal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study
M F Avril, S Aamdal, J J Grob, et al.
British Journal of Cancer
|
April 26, 2012
Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
S Kaye, S Aamdal, R Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, B Kasper, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2002
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report
M Marchand, C J A Punt, S Aamdal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study
M F Avril, S Aamdal, J J Grob, et al.
British Journal of Cancer
|
April 26, 2012
Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
S Kaye, S Aamdal, R Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, B Kasper, et al.
Page
of 7